Brief: Hungary's Richter CEO Says New Strategy Does Not Take Possible New U.S. Tariffs Into Account
05/03/2025 14:42
March 5 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt's CEO Gabor Orban: COMPANY'S NEW LONG-TERM STRATEGY DOES NOT TAKE POSSIBLE U.S. TARIFFS ON EUROPEAN PRODUCTS INTO ACCOUNT AS DETAILS OF TARIFF PLANS ARE NOT YET KNOWN MOST OF RICHTER'S INCOME FROM U.S. COMES FROM ROYALTIES AND ACTIVE INGREDIENTS, WHICH MEANS POSSIBLE TARIFFS WILL HAVE LESS ADVERSE EFFECT ON RICHTER THAN ON THE ENTIRE PRAMACEUTICAL SECTOR POSSIBLE U.S. TARIFFS ON EUROPEAN PRODUCTS COULD AFFECT ITS WOMENS HEALTHCARE AND BIOTECHNOLOGY SALES IN THE LONG TERM Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab